Predictors of chemotherapy dose reduction at first cycle in patients age 65years and older with solid tumors Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Neoplasms

abstract

  • PDR is more common in the palliative setting, but is also utilized among patients treated with curative intent. Factors associated with PDR include age and comorbid conditions, but not KPS.

publication date

  • March 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4477805

Digital Object Identifier (DOI)

  • 10.1016/j.jgo.2014.12.002

PubMed ID

  • 25666905

Additional Document Info

start page

  • 133

end page

  • 40

volume

  • 6

number

  • 2